Filing Details

Accession Number:
0001209191-20-063364
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-14 20:56:03
Reporting Period:
2020-12-10
Accepted Time:
2020-12-14 20:56:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1403708 Evoke Pharma Inc EVOK Pharmaceutical Preparations (2834) 208447886
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578770 J Matthew D'onofrio C/O Evoke Pharma, Inc.
420 Stevens Avenue, Suite 370
Solana Beach CA 92075
Exec Vp, Chief Bus. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-10 5,643 $2.95 324,354 No 4 S Direct
Common Stock Disposition 2020-12-11 40,357 $2.91 283,997 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.9622. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.93. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.